Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2013; 19(2): 274-283
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.274
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.274
Figure 3 Effects of probiotic treatment on plasma glucose, plasma insulin, insulin resistance, plasma C-peptide and plasma thiobarbituric acid-reacting substances in high-fructose diet-fed rats.
Results are expressed as mean ± SE. aP < 0.05 and bP < 0.01 HF control vs chow control by unpaired Student’s t-test; cP < 0.05 and dP < 0.01 week 6 vs week 3 by paired Student’s t-test; ABBars with different capital letters are significantly different at P < 0.05 by Duncan’s multiple range tests. HF: High fructose diet; LP: Low dose probiotic; HP: High dose probiotic; TBARS: Thiobarbituric acid-reacting substances.
- Citation: Park DY, Ahn YT, Huh CS, McGregor RA, Choi MS. Dual probiotic strains suppress high fructose-induced metabolic syndrome. World J Gastroenterol 2013; 19(2): 274-283
- URL: https://www.wjgnet.com/1007-9327/full/v19/i2/274.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i2.274